Login
Israel-Hamas Conflict
Military
Social Media
Protestors
World Cup
Donald Trump
Soccer
War
Benjamin Netanyahu
Rugby
Wrestling
Instagram
WWE
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

bionity.com image

News from bionity.com

We’ve assigned a media bias rating of unknown to bionity.com. You can read more about our methodology here.
If you want to know if bionity.com is credible or reliable, look no further. We rank bionity.com as Unknown factuality. Find out more about our methodology here.

Information about bionity.com

Where is bionity.com located?bionity.com's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Learn more about  Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about  Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top bionity.com News

BioNTech to Buy CureVac in $1.25B Stock Deal That Would Also End mRNA Patent Dispute
Europe · Germany

BioNTech to Buy CureVac in $1.25B Stock Deal That Would Also End mRNA Patent Dispute

47% Center coverage: 28 sources
BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy candidates. Analysts say the M&A deal is a way to essentially settle out of court the ongoing mRNA patent dispute between the companies following some recent CureVac legal wins. The post BioNTech to Buy CureVac in $1.25B Stock Deal That Would Also End mRNA Patent Dispute appeared first on MedCity News.See the Story
Bristol Myers Squibb signs $11bn cancer drug deal with BioNTech
Merck

Bristol Myers Squibb signs $11bn cancer drug deal with BioNTech

66% Center coverage: 18 sources
US-German partnership hopes BNT327 will compete with Merck’s bestseller KeytrudaSee the Story
Europe suffers its largest diphtheria outbreak in 70 years
Homelessness · Montana

Europe suffers its largest diphtheria outbreak in 70 years

58% Center coverage: 12 sources
The largest diphtheria outbreak to strike Western Europe in 70 years has been affecting vulnerable people such as migrants and the homeless since 2022, new research said Wednesday.See the Story

Development and Validation of an Autonomous Artificial Intelligence Agent for Clinical Decision-Making in Oncology

100% Center coverage: 1 sources
Clinical decision-making in oncology is complex, requiring the integration of multimodal data and multidomain expertise. We developed and evaluated an autonomous clinical artificial intelligence (AI) agent leveraging GPT-4 with multimodal precision oncology tools to support personalized clinical decision-making. The system incorporates vision transformers for detecting microsatellite instability and KRAS and BRAF mutations from histopathology sl…Cancer · GermanySee the Story

New Test Improves Quality Control of Allergy Therapeutics

An interdisciplinary research team of the Paul Ehrlich Institute (PEI) from the Departments of Allergology and Veterinary Medicine has developed a novel laboratory test that enables the determination of adjuvanted allergoids in pre-filled medicinal products. Due to the complex structure of these medicinal products,...Germany · GermanySee the Story

Chemical Fingerprints Reveal Fast Food Consumption

A new study by Erikka Loftfield of the National Cancer Institute, USA, and colleagues, published on May 20 in the open-access journal PLOS Medicine, shows that a number of metabolites found in blood and urine are reliably correlated with the amount of energy consumed...Germany · GermanyRead Article

Turning poison into a source of energy

12.06.2025 - A research team led by Stefan Pflügl has succeeded in genetically manipulating the microorganism T. kivui to metabolize carbon monoxide. Stefan Pflügl (left) in the lab with the first authors of the two publications, Angeliki Sitara (center) and Rémi Hocq (right).Vienna, Austria · ViennaSee the Story

Refeyn Announces Change in Management

Refeyn announced that Jonathan Flint will step down as Chairman of the Board after two successful three-year terms. Flint's tenure was marked by significant growth and innovation. The company sincerely thanks him for his exceptional leadership and commitment...Germany · GermanySee the Story

Colon Cancer Screening via Smartphone?

The possibilities for early detection of colorectal cancer have so far been underutilized in Germany. This also applies to the detection of blood in the stool. Immunological stool tests can detect tiny amounts of blood in the stool. Scientists at the German Cancer Research Center (DKFZ) are...Smartphones · GermanySee the Story

Bonus Payments in Large Companies Have Fallen by More than Half

Compared to the previous year, the total income of non-tariff employees in the chemical-pharmaceutical industry remained almost constant in 2024, with an increase of 0.2 percent. This is shown by the current edition of the annual income survey, conducted by the VAA together with the association...Germany · GermanyRead Article

Revolutionary Edible and Biodegradable Fibers Created from Milk Protein and

UNIVERSITY PARK, Pa. – A groundbreaking study conducted by researchers at Penn State has uncovered the potential of milk protein and cellulose derived from plants to pave the way toward sustainable materials. This first-of-its-kind advancement hinges on the innovative electrospinning technique, which utilizes electric forces to transform liquid solutions into fine fibers. The researchers have successfully combined casein, a milk protein, with hy…Pennsylvania · PennsylvaniaSee the Story

Breaking News Topics Related to bionity.com

Baden-Württemberg

Baden-Württemberg

Environment

Environment

Germany

Germany

Cancer

Cancer

Bavaria

Bavaria

Science

Science

Medical

Medical

News
For You
SearchBlindspotLocal